For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Bluebird bio Inc’s stock clocked out at $0.92, up 1.13% from its previous closing price of $0.91. In other words, the price has increased by $1.13 from its previous closing price. On the day, 5.14 million shares were traded. BLUE stock price reached its highest trading level at $0.9458 during the session, while it also had its lowest trading level at $0.8931.
Ratios:
To gain a deeper understanding of BLUE’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.42 and its Current Ratio is at 1.55. In the meantime, Its Debt-to-Equity ratio is 1.36 whereas as Long-Term Debt/Eq ratio is at 1.04.
On December 08, 2023, Morgan Stanley Upgraded its rating to Equal-Weight which previously was Underweight and also upped its target price recommendation from $3 to $7.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 04 ’24 when Obenshain Andrew sold 6,095 shares for $1.53 per share. The transaction valued at 9,311 led to the insider holds 279,998 shares of the business.
Klima Thomas J sold 4,573 shares of BLUE for $6,986 on Mar 04 ’24. The insider now owns 124,840 shares after completing the transaction at $1.53 per share. On Mar 01 ’24, another insider, Colvin Richard A, who serves as the Chief Medical Officer of the company, sold 6,770 shares for $1.53 each. As a result, the insider received 10,342 and left with 118,368 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLUE now has a Market Capitalization of 177862320 and an Enterprise Value of 230309456. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.19 while its Price-to-Book (P/B) ratio in mrq is 0.44. Its current Enterprise Value per Revenue stands at 10.601 whereas that against EBITDA is -1.748.
Stock Price History:
Over the past 52 weeks, BLUE has reached a high of $5.53, while it has fallen to a 52-week low of $0.88. The 50-Day Moving Average of the stock is -26.45%, while the 200-Day Moving Average is calculated to be -62.45%.
Shares Statistics:
It appears that BLUE traded 8.36M shares on average per day over the past three months and 6555450 shares per day over the past ten days. A total of 192.74M shares are outstanding, with a floating share count of 189.83M. Insiders hold about 1.51% of the company’s shares, while institutions hold 62.01% stake in the company. Shares short for BLUE as of 1713139200 were 32620441 with a Short Ratio of 3.90, compared to 1710460800 on 34040621. Therefore, it implies a Short% of Shares Outstanding of 32620441 and a Short% of Float of 18.07.
